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SUMMARY
Cardiac ischemia leads to the loss of myocardial tis-
sue and the activation of a repair process that culmi-
nates in the formationof a scarwhose structural char-
acteristics dictate propensity to favorable healing or
detrimental cardiac wall rupture. To elucidate the
cellular processes underlying scar formation, here
we perform unbiased single-cell mRNA sequencing
of interstitial cells isolated from infarcted mouse
hearts carrying a genetic tracer that labels epicar-
dial-derived cells. Sixteen interstitial cell clusters
are revealed, five of which were of epicardial origin.
Focusing on stromal cells, we define 11 sub-clusters,
including diverse cell states of epicardial- and endo-
cardial-derived fibroblasts. Comparing transcript
profiles from post-infarction hearts in C57BL/6J and
129S1/SvImJ inbred mice, which displays a marked
divergence in the frequency of cardiac rupture, un-
covers an early increase in activated myofibroblasts,
enhanced collagen deposition, and persistent acute
phase response in 129S1/SvImJ mouse hearts,
defining acrucial timewindowof pathological remod-
eling that predicts disease outcome.
INTRODUCTION
Myocardial infarction (MI) is defined by extensive myocardial cell
death due to prolonged ischemia (Thygesen et al., 2018) and re-
mains a main cause of morbidity and mortality worldwide. The
ability to regenerate the heart in lower vertebrates and neonates
has been attributed to the proliferation of pre-existing cardio-
myocytes (Foglia and Poss, 2016), a property that is almost
entirely lost in the adult mammalian heart, where response to
injury results in the formation of a scar. The outcome of the repair
process is highly dependent on the extent of myocardial death
and on the interplay between the inflammatory response and
fibrosis (Forte et al., 2018), which can lead to rupture or adverse
ventricular remodeling and heart failure.
Cardiac interstitial cells are increasingly recognized as main
players in organ injury response. They constitute 60%–70% of
the total cells of the heart and include immune cells, endothelial
cells, smooth muscle cells (SMCs), pericytes, fibroblasts, and
various putative stem cell populations. Traditionally, most
mesenchymal cell types in the heart have been defined and
sub-selected based on the expression of surface markers, but
no stem cell marker identified to date is unique to a particular
stromal cell type, and the relations of putative stem cell sub-pop-
ulations to other mesenchymal cells in the cardiac interstitium
are unclear (Forte et al., 2018). While the existence of any signif-
icant population of resident cardiac stem cells in the adult heart
has been largely disproved (Chien et al., 2019), heterogeneity in
the mesenchymal-stromal fraction of the mammalian cardiac
cellulome likely indicates a spectrum of different functions in
both homeostasis and response to injury (Skelly et al., 2018).
Previous explorations of cardiac cellular diversity in themouse
heart characterizing single-cell transcriptional profiles of major
non-myocyte cell populations (Farbehi et al., 2019; Kretzschmar
et al., 2018; Pinto et al., 2016; Skelly et al., 2018) have yielded
valuable insights into the structure of the cardiac cellulome. To
develop a more definitive compendium of interstitial cell types
and transitions in response to cardiac injury, we applied unbi-
ased single-cell RNA sequencing (scRNA-seq) to profile the pro-
gression of gene expression patterns in cardiac interstitial cells
through the three main phases of post-MI response: inflamma-
tion, proliferation, and maturation. Analysis of multiple closely
spaced time points immediately after MI revealed a rapidly
changing landscape of interstitial cell types, providing a detailed
and comprehensive characterization of cellular features and
building a precise map of stromal cell evolution in response to
injury.
Given the dramatic differences in myocardial response to
infarction among genetically diverse mice (Salimova et al.,
2019), we analyzed two inbred strains, C57BL/6J and 129S1/
SvImJ, to define distinct cellular features at the transition be-
tween inflammatory and proliferative phases, when the two
strains display major differences in the incidence of early rupture
(23% versus 59%, respectively). These studies reveal signifi-
cantly different fibroblast states in hearts that are genetically
prone to post-MI rupture, pinpointing specific cell populations
that define reparative outcome in the damaged myocardium,
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which represent promising targets for anti-fibrotic treatments of
heart failure.
RESULTS
Single-Cell Analysis Defines the Interstitial Cell
Landscape Post-MI
To profile cell dynamics in response to MI, we performed unbi-
ased scRNA-seq on live nucleated interstitial cells using the
10X Chromium technology (Zheng et al., 2017). Since the epicar-
dium, the mesothelium covering the heart, is the major source
(80%) of cardiac fibroblasts in homeostasis (Furtado et al.,
2016; Smith et al., 2011), we traced the stromal component using
C57BL/6J Wt1Cre;RosaZsGreenf/+ mice, in which an enhanced
green fluorescent protein (EGFP) variant (ZsGreen1) marks
epicardial derivatives. To obtain a clean preparation of interstitial
cells, we removed cardiomyocytes, debris, and dead cells by
straining the cell suspension through 40-mmmeshes using mag-
netic beads-based dead cell depletion and sorting for nucleated
(DRAQ+) live (DAPI) cells. A total of 36,847 live, nucleated inter-
stitial cells were captured at homeostasis and at days (d) 1 and 3
(inflammatory phase), 5 and 7 (proliferative phase), and 14 and
28 (maturation phase) post-MI from 7 mice (Figure 1A; Table
S1; Forte et al., 2018). Whole-mount images showed a diffuse
ZsGreen fluorescence in homeostasis, which increased in inten-
sity after injury, transiting from global heart activation (d1) to the
border zone of the infarct (d3–d5) and onward into the scar area
(d5–d28) (Figure 1B). ZsGreen+ cells increased in the late remod-
eling phase, indicating the presence of epicardial-derived cells in
the mature scar (Figure 1C). Global clustering of single-cell tran-
scriptomes (Butler et al., 2018; Zheng et al., 2017) revealed 16
main populations, identified by marker genes preferentially ex-
pressed in each cluster (Figures 1D–1G; Table S2). These popu-
lations included endothelium (Fabp4, Pecam1); lymphatic endo-
thelium (Lyve1, Cldn5); SMCs (Rgs5, Vtn, Kcnj8); Schwann cells
(Plp1, Kcna1); 7 immune cell populations (granulocytes [S100a8,
S100a9], monocytes I [Chil3, Plac8] and II [Saa3, Arg1], macro-
phages [C1qa,Cd68], dendritic cells [DCs;H2ab1,Cd74], B cells
[Cd79a, H2-DMb2], and a mixed T-natural killer [NK] cell cluster
[Nkg7, Ms4a4b, Gzma]); three fibroblast populations (types I
[Col1a1, Gsn, Dcn], II [Wif1, Dkk3], and III [Mt2, Timp1]); myofi-
broblasts (Myofb; [Cthrc1, Acta2, Postn]); and epicardium (Clu,
Dmkn)—all of these are described in more detail in Figures 1D
and 1E.
ZsGreen expression marking epicardial origin was predomi-
nant in five clusters: epicardium, smooth muscle, and fibroblast
types I–III (Figures 1E and S1A). Co-expression of Wt1 and
ZsGreen marked a minor percentage of endothelial (1%) and
smooth muscle (2%) cells, as well as the activated post-MI
epicardium, indicating de novo expression of the gene, verified
using immunofluorescence (Figures S1B–S1D). No de novo
expression of Wt1 mRNA was seen in fibroblasts, confirming
that post-MI activated fibroblasts derive from the pre-existing
Wt1Cre;RosaZsGreenf/+ labeled pool of cells.
A dynamic and choreographed contribution of cell types
evolved during infarct resolution (Figures 1F and 1G). Innate im-
mune cells accumulated immediately after MI (Figures 1D–1G):
short-lived neutrophils peaked within 24 h (Forte et al., 2018),
monocytes appeared between d1 and d7, and macrophages
peaked d3–d7. Cell ratios returned to near-homeostatic levels
during the maturation phase of MI (d14–d28), with fibroblasts
and endothelial cells prevailing over immune components (Fig-
ure 1G). Whereas a significant fraction of new cell types and
states were observed in the stromal and innate immune cell ag-
gregates during recovery from MI, adaptive immune and
vascular/mural cells were relatively stable (Figure S2).
Dynamics of Stromal Populations Involved in Scar
Formation
To obtain a more detailed portrait of stromal transition from ho-
meostasis (Furtado et al., 2014; Pinto et al., 2016; Skelly et al.,
2018) to post-MI response, fibroblast types I–III, Myofb, and
mesothelial epicardial populations were aggregated and sub-
clustered. Twelve sub-clusters were obtained (Figures 2A, 2B,
S3, and S4; Table S3). Cellular trajectories were defined using
SPRING (Weinreb et al., 2018) (links to SPRING visualization in
Figure S2C). Predictions using DoubletFinder (McGinnis et al.,
2019) revealed an overall very low percentage of predicted dou-
blets across clusters and sub-clusters (Figure S3). Three clusters
were excluded from further analyses due to low cell representa-
tion or mixed identity: a small cluster defined by interferon-
response (IFNr) genes (Ifit3, Isg15, Ifit1), a few dendritic-like cells
(Cd52,C1qb) with a relatively higher frequency of predicted dou-
blets (0.5%; Figure S3) compared to other clusters and sub-clus-
ters, and phagocytic cells (mixed myeloid-Myofb signature;
Actb,Notch2, Lyz2, P2y12). The latter cells were enriched during
the post-MI proliferative phase (d3–d7) and were transcription-
ally similar to proliferating Myofb (Figure S4B), presenting a
relatively higher expression of genes involved in metabolic pro-
cesses and oxidative phosphorylation (Figures 2E and S4).
Within the type I fibroblast population, three closely related
populations of ZsGreen+ epicardial-derived fibroblasts (EpiDs)
were obtained and defined, based on temporal prevalence
and/or marker expression, as homeostatic epicardial derived fi-
broblasts (HEpiDs), progenitor-like state fibroblasts (PLSs), and
late-resolution (LR) fibroblasts. HEpiDs were characterized by
a relatively higher level of expression of genes associated with
the response to organic substances and metabolic effectors:
Dpep1, a zinc-dependent metalloproteinase involved in gluta-
thione and leukotriene metabolism, which may have a role in
transforming growth factor b (TGF-b)-induced epithelial-mesen-
chymal transition (EMT) (Park et al., 2016); Lpl, important for lipo-
protein triglyceride metabolism (Ferna´ndez-Borja et al., 1996;
Xie et al., 2018); Hsd11b1, which converts cortisol to its inactive
form, cortisone, and may affect dermal fibroblast proliferation
(Terao et al., 2014); and the pleiotropic chemokine Cxcl14
(Hara and Tanegashima, 2012; Lu et al., 2016; Figures 2C–2E
and S4C). PLSs were relatively stable across all time points (Fig-
ure 2B), expressed genes associated to cell migration and
morphogenesis, known stromal cell markers Cd248 (Smith
et al., 2015), Pi16 (Regn et al., 2016; Xie et al., 2018), and rela-
tively higher levels of Ly6a, previously used as a marker to enrich
for putative cardiac progenitor cells (Tang et al., 2018; Farbehi
et al., 2019; Oh et al., 2003; Figures 2C–2E and S4C). LR
fibroblasts were prevalent at d14–d28 (maturation phase), ex-
pressing a relatively higher level of genes associated with cell
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differentiation, osteogenesis, and regulation of matrix remodel-
ing and deposition, including Adamtls2 and Cilp, secreted pro-
teins involved in the negative regulation of TGF-b availability
(Le Goff et al., 2008) and activity (Zhang et al., 2018), fibrillogen-
esis (Koo et al., 2007), and fibrosis (van Nieuwenhoven et al.,
2017; Zhang et al., 2018); Col8a1, an extracellular matrix (ECM)
component conferring tensile strength that supports vessel
integrity and structure (Kittelberger et al., 1990) upregulated in
Figure 1. Single-Cell RNA-Seq of Interstitial Cells Post-MI Reveals Population Dynamics in Cardiac Repair
(A) Murine cardiac interstitial cells were isolated by mechanical and enzymatic dissociation of adult mouse cardiac ventricular tissue (dashed square); mesh
purification, magnetic dead cell depletion, and sorting were performed to exclude cardiomyocytes and apoptotic or necrotic cells before analysis. A total of
38,600 cells were captured and sequenced (n = 7 mice).
(B) Selected time points and whole-mount images of Wt1cre;ZsGreenf/+ mice used to trace epicardial-derived components in the cardiac interstitium.
(C) Percentage of single live nucleated ZsGreen+ interstitial cells detected by flow cytometry in the samples used for scRNAseq. Data shown asmean ± SD of two
technical replicates at each time point.
(D) t-Distributed stochastic neighbor embedding (t-SNE) plot of the aggregate of all sequenced cells across time points. Seurat analysis with 24 PC and resolution
0.5 was used to define 16 main clusters.
(E) Dot-plot visualization of top marker genes used to identify clusters. Dot sizes denote percentage of expression per cluster; color gradient defines average
expression per cell.
(F) t-SNE plot showing cell contribution by time point identified by color.
(G) Bar plot of percentage of cluster contributions per time point.
See also Figures S1 and S2 and Tables S1 and S2.
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Figure 2. Evolution of Fibroblast States across Phases of Repair
(A) t-SNE plot of combined stromal clusters (fibroblasts I, II, and III, myofibroblasts) and epicardium, further sub-clustered by 20 PC, resolution 0.5, colored by
cluster separation.
(B) Bar plot representation of the relative frequency of different fibroblast sub-clusters (percentage over total cells) at different time points across repair.
(C) Dot-plot representation of top two signature genes per sub-cluster.
(D) SPRING visualization of fibroblast sub-clusters; 1,200 cells are shown per time point, colored by Seurat-defined clusters.
(E) PANTHER GO-slim biological process overrepresentation analysis of fibroblasts sub-cluster marker genes, showing representative GO terms per each sub-
cluster, excluding DCs, dendritic-like cells, and IFNr (interferon-responsive cells). Bonferroni corrected p values.
See also Figures S2–S4 and Tables S3 and S4.
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the presence of vascular injury (Gerth et al., 2007; Kittelberger
et al., 1990; Lopes et al., 2013); and the transcription factor
Meox1, which is involved in embryonic somitogenesis and
TGF-b-induced differentiation of SMCs (Dong et al., 2018; Fig-
ures 2C–2E and S4C).Meox1 is also implicated in cardiac path-
ological hypertrophy (Lu et al., 2018) and is downregulated
during in vitro phenoconversion from fibroblasts to Acta2+
Myofb (Cunnington et al., 2014). The observed gene expression
pattern of LR fibroblasts and their prevalence during the matura-
tion phase suggests that these cells arise as a consequence of
chronic pathological remodeling rather than as direct precursors
of Acta2+Myofb, aswas recently suggested (Farbehi et al., 2019).
The SPRING k-nearest neighbor (knn) graphical representa-
tion of stromal cells showed a linear progression from EpiD
ZsGreen+ to Myofb (Figure 2C). Type II fibroblasts (Wif1, Dkk3)
appeared as a distinct sub-cluster, branching separately in the
SPRING plot (Figure 2D) and characterized by a gene signature
closely related to valve leaflets, with top canonical pathways
involved in endochondral ossification and Wnt signaling and
Gene Ontology (GO) terms related to anatomical structure
morphogenesis and development (Figures 2C–2E, 3E, and
S4C). Given the low level of ZsGreen expression in these cells,
possibly due to ambient RNA contamination, they are likely
endocardial-derived fibroblasts (EndD). Consistently, 88.5% ±
2.27% of the DKK3+ cells in the ventricles were co-labeled
with ZsGreen in TekCre;ZsGreenf/+ mice (which trace endocar-
dial-derived cells), while 88.05% ± 4.02% of EndD cells were
ZsGreen in Wt1Cre;RosaZsGreenf/+ mice (Figure 3). A similar
population, recently referred to as Wnt-X (Farbehi et al., 2019),
was considered an activated state, since WIF1 protein was
observed immediately after injury in the peri-infarct area (Fig-
ure S4D). In contrast, our analysis showed the expression of
the signature marker DKK3 already in homeostasis around cor-
onary vessels and valve fibroblasts (Figure 3), suggesting that
the segregation of the EndD as a sub-population of fibroblasts
may be due to its embryological origin, rather than to an activa-
tion state (Figure 2D).
A sub-cluster of ZsGreen+ EpiD cells, defined by its injury
response (IR) properties, and expressing high levels of Mt1-2
transcripts (Figures 4 and S4B), appeared at d1, preceding
Myofb at d3 (Figure 2B). MT1-2 metallothioneins are involved
in the alleviation of oxidative stress and immunomodulation
(Subramanian Vignesh and Deepe, 2017), and transient Mt1-2
activation in stress conditions or inflammatory diseases (De
et al., 1990) exerts a protective function by reducing apoptosis
and excessive fibrosis (Duerr et al., 2016). The IR sub-cluster
also showed a high expression of monocyte-macrophage che-
moattractants Ccl2, Ccl7, and Csf1 and neutrophil activators
Cxcl1 and Cxcl5; pro-inflammatory-pro-fibrotic factors Il33,
Cxcl12, and Tgfb1 (Figure 4B); the metalloprotease inhibitor
Timp1, which blocks Mmp1 but can additionally prevent
apoptosis and induce proliferation in a range of cell types
(Brew and Nagase, 2010); the Mmp3 metalloprotease, which
can degrade the major components of the ECM but not intersti-
tial collagen I (Lu et al., 2011); andmatricellular proteins with pro-
inflammatory or pro-reparative functions such as Prg4 (Iqbal
et al., 2016) and Angptl4 (Jamil et al., 2017; Teo et al., 2017).
This complex cocktail of regulatory factors implicates the IR
cell cluster in the initiation of the inflammatory response and for-
mation of granulation tissue. GO biological terms and canonical
Figure 3. Endocardial-Derived Fibroblast (EndD) Validation in Homeostatic Ventricles
(A) Confocal imaging of the EndD marker DKK3 (in red) on cardiac sections from adult Wt1Cre; ZsGreenf/+ mice. ZsGreen labels epicardial derived cells.
(B) Quantification of the percentage of DKK3+ cells co-labelled with the reporter ZsGreen. Data are represented as mean ± SEM. N = 3 biological replicates,
7 technical replicates.
(C) Confocal imaging of DKK3 (in red) on cardiac sections from adult TekCre; ZsGreenf/+ mice. ZsGreen labels endocardial-derived cells.
(D) Quantification of the percentage of DKK3+ cells co-labelled with the reporter ZsGreen. Data are represented as mean ± SEM. N = 3 biological replicates, 7
technical replicates.(E) Enrichr analysis of EndD marker genes identified top related cell (mouse gene atlas) and tissue (ARCHS4 tissues) types.
See also Figure S4 and Tables S3 and S4.
Cell Reports 30, 3149–3163, March 3, 2020 3153
(legend on next page)
3154 Cell Reports 30, 3149–3163, March 3, 2020
pathways associated with this cluster included ribosome
biogenesis; regulation of eukaryotic translation initiation factor
2 (eIF2), eIF4, and p70S6K, indicating active protein synthesis
and translation; and acute phase response signaling (Serpina3n,
Serpina1, Tnfrsf1a), involved in the unfolded protein response
and glycolysis (Figures 2E and 4C). To confirm the expression
of MT1-2 in stromal cells, immunostaining was performed
on Wt1cre;ZsGreenf/+, to verify the epicardial origin, and
Col1a1eGFP mice, for quantification. While in homeostasis,
MT1-2 proteins were expressed mostly in CD45+ cells
(88.9% ± 5.4% of CD45+ cells, 4% ± 1.3% of Col1a1-EGFP+
cells; Figures 4D and 4E), reflecting their role in immune cell
maturation (Subramanian Vignesh and Deepe, 2017); global acti-
vation was detected at d1 in EpiD (ZsGreen+) stromal cells,
extending from the injury site to remote myocardial areas
(62.7% ± 2.5% of Col1a1-GFP+ cells Figures 4D and 4E). At
d3, MT1-2+ stromal cells were reduced and mostly confined to
the scar area (29.6% ± 5% of Col1a1-GFP+ cells in the scar
area versus 6% ± 0.2% distal area), labeling a fraction of Myofb
defined by anatomical position, morphology, and high expres-
sion of Col1a1-GFP. MT1-2+ was mostly limited to CD45+ and
sub-epicardial cells at d5. Consistently, SPRING analysis
showed that the IR cluster evolved from high expression of
Mt1-2 and stromal and fibroblast genes (Gsn [Witke et al.,
1995], Pdpn [Suchanski et al., 2017], Angptl4) on d1 to low
expression of Mt1-2 accompanied by Myofb markers (Fn1,
Acta2, Cthrc1) on d3 (Figure 4F), suggesting that IR cells rapidly
transition to Myofb, in contrast to a previous report suggesting
the appearance of Myofb not earlier than d7 post-MI (Farbehi
et al., 2019).
Myofb, large cells with highly active endoplasmic reticulum,
are defined as specialized fibroblasts that appear post-injury,
produce a high quantity of ECM components, and acquire
some phenotypic and functional features of SMCs, such as
contraction capacity upon stimulation, essential for the closure
and stabilization of the injury site (Baum and Duffy, 2011; Forte
et al., 2018). Our analysis showed a linear progression from
EpiD ZsGreen+ to Myofb (Figure 2D). Three main populations
of Myofb were observed post sub-clustering: Myofb (Acta2,
Cthrc1), ProlifMyofb (Acta2, Cthrc1, cell-cycle genes) from d3
to d7, and a group of cells similar to the recently defined matrifi-
brocytes (MFCs) (Fu et al., 2018) enriched in the mature scar
(d14–d28). MFCs expressed genes related to osteoblasts and
chondrocytes, similarly to EndD fibroblasts (Figure 5), such as
cartilage oligomeric matrix protein (Comp), an ECM protein pre-
sent in cartilage that catalyzes the assembly of collagens and
formation of fibrils (Hala´sz et al., 2007), and genes associated
with fibrosis and collagen signaling, similar to LR fibroblasts
and Myofb. Pairwise differential gene expression analysis of all
fibroblast states using Seurat revealed that, compared to
EndD, MFCs had higher levels of ECM components (Col8a1,
Fn1, Fbn1, Itgbl1, Wisp2, and Cthrc1) and notably did not ex-
press the Wnt inhibitor Wif1 (Figure S4C; Table S4). Compared
to Myofb, MFCs had reduced expression of genes associated
with contractility (Acta2, Tagln, Tpm2, andMyl9) or ECM compo-
nents (Timp1, Tnc, Cthrc1, and Col1a1), but expressed Comp
and Angptl7 and Fbln1 and Cilp, supporting the transition to a
less contractile, less secretory cell type producing components
of a more stable, chondrogenic-like ECM.
To visualize the conversion between these two cell types in the
injury site, immunofluorescence was performed using ACTA2
and CTHRC1 as Myofb markers. MFC markers included
SFRP2, a pro-reparative paracrine factor (Mirotsou et al.,
2007), and CLU, a widely expressed glycoprotein upregulated
in senescent fibroblasts or under different stress conditions.
CLU may play a role in apoptosis, debris removal, and folding
of secreted proteins (Jenne and Tschopp, 1992; Jones and Jo-
mary, 2002; Figures 5B and 5C). ACTA2 staining in Myofb was
seen at a lower intensity than in SMCs starting from d3, and
was mostly limited to vessels at d14–d28, while Myofb CTHRC1
staining persisted at late stages. InMFCs, SFRP2 andCLU stain-
ing increased at later stages; the latter was also expressed in
activated endocardium and epicardium (Figure 5C). qPCR anal-
ysis on Col1a1-EGFP+ stromal cells isolated from the scar and
distal myocardial areas of the heart at d5–d14 post-MI confirmed
that Myofb markers Acta2 and Tnc were significantly higher in
the scar during the proliferation phase (d5), while MFC markers
Ecrg4,Comp,Sfrp2, Thbs4,Wisp2,Meox1, andCol8a1were up-
regulated at d14. Meox1, Comp, Ecrg4, and Col8a1 were unal-
tered or not significantly changed in the d5 distal area compared
to the control, confirming their enrichment in LR fibroblasts.
These results underscore the dynamic stromal response to car-
diac injury, which induces a complex orchestration of multiple
cell subtypes responsible for post-MI remodeling.
Genetically Determined Factors Confer Resilience to
Cardiac Rupture
Genetic background dictates differences in initial cardiac stro-
mal cell composition that may influence the course of replace-
ment fibrosis in cardiovascular disease (Forte et al., 2018;
Salimova et al., 2019). Here, we took advantage of the genetic
diversity across inbred mouse strains to investigate the variation
in response to MI: C57BL/6J or B6J (control), 129S1/SvlmJ or
129 (prone to hypertension), DBA/2J (prone to calcification),
Figure 4. An Epicardial-Derived Injury Response (IR) Fibroblast Population in the Early Phase of Repair Post-MI
(A) Heatmap of the average expression of the top 20 signature IR cluster genes across all fibroblast sub-clusters.
(B) Top cytokines and chemokines produced by the IR cluster.
(C) Top IR cluster canonical pathways identified using Ingenuity Pathway Analysis (IPA).
(D) Confocal imaging of MT1-2 staining in IR fibroblasts at d1 and d3 post-MI using Wt1cre;ZsGreenf/+ and Col1a1eGFP reporter mice.
(E) Scatterplot showing the percentage ofMT1-2+ cells co-labeled with the reporterCol1a1eGFP or CD45 (gray). A total of 5–10 frameswere counted per each time
point, 2–3 mice per time point. Data are represented as means ± SEMs. LV (green dot) is the left ventricle injury site; RV/Distal (red triangle), right ventricle, area
distal from the injury site.
(F) SPRING visualization of the IR sub-cluster showing time course evolution of cluster identity (blue arrow) from fibroblast (Fb) to myofibroblast (Myofb). Plots on
right panels show marker genes that distinguish early (Fb) from late (Myofb) IR cells. Scale bars, 50 mm.
See also Figure S4 and Tables S3 and S4.
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Figure 5. Contribution of Myofibroblasts (Myofb), Matrifibrocytes (MFCs), and Late Response Fibroblasts (LR) to Ventricular Remodeling
Post-MI
(A) knn SPRING visualization of theMyofb cluster identified from analysis of the stromal aggregate across 7 time points (PC24, resolution 0.5), colored by time and
by the expression of early Myofb marker genes (Acta2, Tnc, Cthrc1, light blue) and MFC marker genes (Sfrp2, Clu, Ecrg4, Comp, Wisp2, Thsb4).
(B and C) Confocal imaging of adult hearts fromCol1a1eGFPmice, used as a genetic marker for stromal cells. (B)Myofbmarkers CTHRC1 (red) and ACTA2 (white)
and (C) MFC markers SFRP2 (red) and CLU (white) at different time points post-MI.
(D) qPCR validation of additionalMyofb (light blue), MFC (dark blue), and LR (olive green) markers on live nucleated stromal cells (PI, DRAQ5+, EGFP+) sorted
fromCol1a1eGFP transgenic hearts. Scar or distal areas were dissected and separately processed for sorting from control (n = 3) or d5 (n = 3) and d14 (n = 3) post-
MI ventricular tissue.
(legend continued on next page)
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NOD/ShiLtJ (prone to type 1 diabetes), NZO/HlLtJ (obese), A/J
(prone to muscular dystrophy), and three wild-derived strains
(CAST/EiJ, WSB/EiJ, and PWK/PhJ) (Figure 6A). The mortality
Data are summarized as box andwhisker plots, indicating themedian value (black bar inside box), 25th and 75th percentiles (bottom and top of box, respectively),
and minimum and maximum values (bottom and top whisker, respectively). Statistical significance (*p < 0.05, zp < 0.001, #p < 0.0001) was calculated per each
gene by two-tailed unequal variance Student’s t test between sample (distal d5, distal d14, scar d5) and correspondent reference used for normalization (distal
d0, scar d14). Scale bars, 50 mm.
See also Figure S4 and Tables S3 and S4.
Figure 6. Differential Rupture Rate and Stro-
mal Cell Response across Inbred Murine
Strains
(A) Pie charts showing 1-month survival rate post-
MI of 9 inbred strains with different susceptibilities
to cardiovascular dysfunction, including diabetes
(NOD/ShiLtJ, n = 13), obesity (NZO/HILtJ, n = 16),
hypertension (129S1/SvlmJ, n = 34), calcification
(DBA/2J; n = 9), dystrophic myopathy (A/J; n = 14),
and wild-derived strains (CAST/EiJ, n = 18; WSB/
EiJ, n = 12 and PWK/PhJ, n = 11). C57BL/6J was
used as a control (n = 13).
(B) Representative whole-mount images of 129S1/
SvlmJ and C57BL/6J hearts at homeostasis and
d3 post-MI.
(C) t-SNE plot of combined interstitial cells from
C57BL/6J and 129S1/SvlmJ hearts (B6J sham,
n = 2, 4,710 cells; 129 sham, 4,213 cells; d3 MI
B6J, 3,950 cells; d3 MI 129, 4,128 cells). Twenty-
seven clusters were obtained using unbiased
clustering.
(D) Relative ratio of various stromal cell populations
in 129 and B6J hearts at d3 sham or MI (mean
cells per thousand). Two B6J sham samples were
used to show consistency between biological
replicates.
See also Figures S5 and S6 and Table S5.
rate varied among strains, with 129
showing the highest rate of rupture
(59%; n = 34) when compared to B6J
(23%; n = 13), as previously described
(Gao et al., 2005). The baseline cardiac
function of both lines was similar (Fig-
ure S5), despite previous reports of higher
blood pressure in 129 males (Barrick
et al., 2007), attributed to the increased
activity of the renin-angiotensin system
(RAS) pathway (Lum et al., 2004; Wang
et al., 2002), which promotes inflamma-
tion (Gao et al., 2017). Rupture occurred
between d4 and d5 in B6J and d3 and
d4 in 129 (Figure S5K), similar to previous
reports (Gao et al., 2005) and coinciding
with the transition from the inflammatory
to the proliferative phase and of fibroblast
state from IR to Myofb.
To understand how differences in cell
composition and/or gene expression
may determine the higher propensity to
rupture in 129, scRNA-seq of 129 and B6J cardiac interstitial
cells were compared in sham-operated mice and at d3 post-
MI (Figure 6B), the crucial pre-rupture time point. Data were
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integrated, using Harmony, an algorithm that projects cells into a
shared embedding while accounting for a biological variable—in
this case, genetic background (Korsunsky et al., 2019; Fig-
ure 6C). The comparison to sham-operated mice that were sub-
jected to a similar procedure, with chest opening and tearing of
the pericardium, allowed us to focus on the differences caused
by the ischemic injury alone. Post-MI 129 hearts presented rela-
tively more Myofb, ProlifMyofb, and IR fibroblasts than B6J (Fig-
ure 6D), at the expense of other fibroblast states, which were
balanced or relatively reduced in 129 (Figures S6A and S6B).
Within the stromal cluster aggregate (Figure S6C), 3,922 genes
were differentially expressed between 129 and B6J as a function
of strain and MI (Tables S6 and S7). PANTHER analysis defined
differences in pathways related to inflammation, receptor tyro-
sine kinase signaling, cell migration, ECM organization, and
collagen formation between strains (Figures 7A, S7A, and
S7B). Ingenuity Pathway Analysis (IPA) confirmed the enrich-
ment in pathways related to fibrosis, adhesion, growth, and
inflammation, and predicted upstream regulators, including
pro-inflammatory and pro-fibrotic factors (Tgfb1, Tnf, Ifng, Il1b,
Il4, Agt) (Figure S8). The expression of genes within GO cate-
gories for ossification, ECM organization, ECM structural com-
ponents, and collagen-containing matrix were relatively reduced
in 129 sham, but upregulated in 129 at 3d post-MI compared
with B6J (Figures S7C and S7D). Within ECM components,
elasticity genes (Eln, Emilin2, fibulins, microfibrillar-associated
Figure 7. Differential Pro-inflammatory and Secretory Phenotypes and ECM Composition between 129 and B6J Cardiac Stromal Cells
(A) PANTHER Reactome pathway analysis of 3,922 differentially expressed genes (FCR 2; p < 0.01) between sham or d3 post-MI 129 and B6J stromal cells.
(B–D) Dot plots showing the percentage and intensity of expression of genes within representative GO terms related to angiotensin response (B), ECM
composition (C), and acute phase response and coagulation (D) across all of the samples. Two B6J sham samples were used to show consistency of change
between biological replicates. Percentage scores denote the number of genes within the GO term that are represented in the list of differentially expressed genes.
(E) qPCR validation of gene changes across samples. Sorted CD45/CD31 stromal cells were isolated from adult 129 and B6J d3 sham or post-MI hearts (n = 3
biological and technical). Target genes were grouped as Myofb markers, ECM components, genes regulating ECM composition, coagulation, acute phase
response, chemokine activity, and renin-angiotensin system (RAS).
Data are summarized as box andwhisker plots, indicating themedian value (black bar inside box), 25th and 75th percentiles (bottom and top of box, respectively),
and minimum and maximum values (bottom and top whisker, respectively). Statistical significance (*p < 0.05, zp < 0.001, #p < 0.0001) per each gene was
calculated by two-tailed unequal variance Student’s t test, comparing expression values in 129 versus B6J reference samples used for normalization.
See also Figures S7–S9 and Tables S6 and S7.
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proteins) were relatively lower in 129 irrespective of injury (Fig-
ure 7C and S7D), while tensile-strength collagens (Fn1, Tnc,
Thbs1, Vcan)were upregulated in 129 post-MI. ECM-associated
enzymes (Adamts2, Adamts5, Lox, Loxl2, Bmp1) were also
higher in 129 post-MI, while metalloproteinases were increased
in B6J (Figures S8C and S8D), with the exception of Mmp9, or
gelatinase B, which was previously associated with cardiac
rupture (van den Borne et al., 2009), and Mmp14, a mem-
brane-associated metalloprotease involved in the activation of
MMP2, or gelatinase A (Jugdutt, 2003). ECM components
involved in the inflammatory response (Hif1a, Timp1, F2r) were
upregulated in 129 post-MI (Figures 7C and S7E), as well as
coagulation genes (F2r, Pf4) and negative regulators of fibrino-
lysis (Serpine1, Thbs1) (Figure 7D). Mouse strain 129 also ex-
pressed relatively higher levels of acute phase response genes
(Tlr4, Serpina3n, Saa3) both in sham and post-MI, and increased
chemoattractant or chemokine activity post-MI, with the excep-
tion ofCxcl14,which was already higher in 129 sham (Figures 7D
and S7E).
Among its numerous functions, the RAS is involved in ECM
deposition through stimulation of the AgtR1 (Mehta and Grien-
dling, 2007). Angiotensin II (AngII) induces a secretory phenotype
in fibroblasts, stimulating the production of chemokines and
ECM components (Bouzegrhane and Thibault, 2002), as well
as pro-fibrotic factors, including TGF-b1 (Rosenkranz, 2004).
AngII plays an essential role in promoting liver fibrosis by upregu-
lating Toll-like receptor 4 (TLR4), thus enhancing downregulation
of the TGF-b1 inhibitory pseudo-receptor BAMBI (Li et al., 2013).
Consistently, our single-cell data showed a relative increase in
Agt1ra, its downstream targets Tlr4, Tgfb1, and Ctgf (Figure 7B),
and reduced Bambi in 129 stromal cells post-MI (Figures S8C
and S9).
In summary, the increased susceptibility of 129 hearts to
rupture is associated with persistent coagulation and impaired
fibrinolysis that increases instability in the injury site, which is
also supported by the higher responsiveness to angiotensin (Fig-
ures 7B, S7B, and S9). The increased production of ECM com-
ponents in 129 post-MI does not confer resilience to rupture;
rather, other ECM properties, such as fiber alignment, or physi-
ological differences in baseline ECM composition, have been
suggested as critical factors for heart repair following injury
(Gao et al., 2002; Richardson and Holmes, 2016; Salimova
et al., 2019).
DISCUSSION
In the heart, interstitial cells of varying identities provide impor-
tant regulatory functions in tissue homeostasis and repair, and
an accurate evaluation of their composition is essential for
defining their respective roles during pathogenesis and for
devising strategies for tissue engineering and other therapeutic
intervention. Our previous studies offered insights on the abun-
dance and characteristics of different interstitial cell types in
the heart, aided by isolation strategies and genetic tools to define
and manipulate fibroblasts (Furtado et al., 2014), refined flow
cytometry techniques (Pinto et al., 2012, 2016), and unbiased
single-cell analysis (Skelly et al., 2018) in the absence of cardio-
myocytes, without relying on surface markers that may overlap
different cell states and conceal heterogeneity (Ackers-Johnson
et al., 2018; Jaitin et al., 2014). We also drew on recent work
leveraging mouse genetic diversity for the discovery of the
gene networks associated with variations in cardiovascular dis-
ease outcomes (Salimova et al., 2019).
The inclusion of a genetic reporter distinguished multiple EpiD
subtypes (HEpiD, PLS, LR, IR, Myofb, MFC) whose sequential
appearance defined post-MI phases, as well as an endocar-
dial-derived cell population (EndD) expressing genes involved
in endochondral ossification and Wnt signaling inhibition, whose
stable presence in homeostasis persisted throughout repair.
Detailed profiling of the dynamic transcriptional changes across
three phases of cardiac response to infarction (inflammatory,
proliferative, and maturation) revealed a rapid induction of dy-
namic injury-induced transitions in interstitial cell states,
including an emerging fibroblast subset associated with inflam-
matory initiation that marked the inherited characteristics of
pathogenic outcomes.
In contrast to previous scRNA-seq studies in cardiac post-
ischemic injury (Farbehi et al., 2019; Kretzschmar et al., 2018),
the analysis of multiple time points (d1, d3, d5, d7) immediately
post-MI has provided a higher resolution of the early dynamic
transitions in stromal cells that predict survival versus cardiac
rupture. Whole-heart activation soon after injury identified an
IR signature in fibroblasts and in a fraction of early Myofb, ex-
pressing molecular markers of oxidative stress alleviation and
immunomodulation. A detailed analysis of the proliferative phase
(d3, d5, d7) revealed a prevalence of Myofb and their cycling
counterparts (ProlifMyofb) and a phagocytic population with
mixed fibroblastic-myeloid identity (Arlein et al., 1998). Profiles
of later post-MI stages (d14, d28) identified a population of
EpiD (LR), expressing genes modulatory of TGF-b activity and
availability and regulatory of ECM components involved in tissue
remodeling and pathological hypertrophy. A similar cell type
(F-actin) has been recently defined as a pre-Myofb activation
state in which fibrosis is inhibited (Farbehi et al., 2019). Given
that LR are prevalent in the distal infarct area during the matura-
tion phase, when Myofb are replaced by MFC derived from
Acta2+ cells (Fu et al., 2018), LR are most likely not direct Myofb
precursors, but rather a state indicative of chronic remodeling.
Our current analysis confirmed that MFCs are closely related
to Myofb (Fu et al., 2018), but have reduced contractile and
secretory properties, expressing different matrix components
associated with late remodeling and ossification.
The early transition of IR to Myofb is likely an important step in
determining reparative outcome, considering the high preva-
lence of cardiac rupture in 129 hearts in the early proliferative
phase (d3–d4). Clear differences in the stromal compartment
of 129 hearts showed a prevalence of Myofb and IR Myofb,
with a stronger pro-inflammatory and secretory state, including
increased production of chemokines, inflammatory signals,
and ECM components, as compared to B6J hearts. This pheno-
type is correlated with an enhanced response to angiotensin. A
high responsiveness to the RAS pathway may be due to the
presence of a duplication of the Renin gene in the 129 strain,
the function of which is still not completely clear (Lum et al.,
2004; Wang et al., 2002). Treatments with therapeutic drugs tar-
geting the RAS pathway cause a significant reduction in the
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frequency of rupture in 129, independently from changes in
blood pressure, and attributed to reduced inflammatory infiltra-
tion (Gao et al., 2017). Here, significant differences in the
single-cell transcriptomic analysis, combined with bulk qPCR
validation in the stromal compartment of the 129 mice, are in
line with the pleotropic functions of angiotensin, which not only
regulates the recruitment of myeloid cells from the spleen (Swir-
ski et al., 2009) but also promotes fibrosis and collagen deposi-
tion by fibroblasts (Lijnen et al., 2001; Mehta and Griendling,
2007). While it may seem paradoxical that mice with more
ECM-secreting Myofb are prone to rupture, the reduced expres-
sion of collagens and ECM components conferring elasticity in
129 homeostatic hearts suggest that pre-existing scaffolds are
more important than newly secretedmatrices in conferring resis-
tance to rupture (Gao et al., 2002). An alternative explanation for
this phenomenon is that the quality, organization, andmaturation
of the matrix is more important than its pure enhanced secretion.
In addition, gene expression patterns indicate that persistent
coagulation and reduced fibrinolysis in 129 may contribute to
the instability of the injury site.
The 129 model resembles the more common cardiac rupture
of the pre-reperfusion era (type III), characterized by transmural
myocardial necrosis with hemorrhagic transformation in the cen-
tral region (Becker and van Mantgem, 1975). The present study
pinpoints the modulation of the early transition from IR to Myofb
as a critical determinant for risk of rupture and pathological re-
modeling in the 129 model and proffers mechanistic insights
into the previously reported beneficial effects of fibrinolytic and
anti-RAS therapies in these patients (Bates, 2014; Honda et al.,
2014). It presents a comprehensive profile of cell types and path-
ways for the modulation of fibrosis as a critical intervention post-
MI, providing potential targets for anti-fibrotic intervention. The
detailed transcriptomic analysis of cardiac interstitial cells at
different time points post-MI provides a benchmark for compar-
ative analyses of potential differences in cell composition and
dynamics of genetically diverse models with different reparative
outcomes. Future mapping of the networks controlling the fibro-
blast IR state promises to identify specific features conferring
susceptibility and resilience to cardiac rupture, enabling patient
stratification and the development of precision therapies.
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Forte (elvira.forte@jax.org). This study did not generate new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal models
All animal procedures were approved by the JAX Institutional Animal Care and Use Committee (IACUC) under the license 16010 and
comply with NIH regulations. For constitutive epicardial genetic tracing, males from theWt1Cre transgenic line (del Monte et al., 2011;
Wessels et al., 2012) were crossed with the reporter B6.Cg-Gt(ROSA)26Sortm6(CAG-ZsGreen1)Hze/J (named ZsGreenf/+ in this work; JAX
Continued
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Mouse: 129S1/SvImJ The Jackson Laboratory JAX: 002448
Mouse: PWK/PhJ The Jackson Laboratory JAX: 0003715
Mouse: CAST/EiJ The Jackson Laboratory JAX: 000928
Mouse: A/J The Jackson Laboratory JAX: 000646
Mouse: C57BL/6J The Jackson Laboratory JAX: 000664
Mouse: DBA/2J The Jackson Laboratory JAX: 000671
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Vevo LAB software FUJIFILM/VisualSonics Inc.,
Canada
https://www.visualsonics.com/product/
software/vevo-lab
CellRanger v2.1 10x Genomics https://support.10xgenomics.com/single-
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latest/installation
STAR aligner Dobin et al., 2013 STAR; RRID:SCR_015899
g2gtools Keane et al., 2011 https://github.com/churchill-lab/g2gtools
R version 3.4.1 R Development Core Team, 2017 https://cran.r-project.org/bin/macosx/
Seurat software package version 2.3.4 Butler et al., 2018; Macosko
et al., 2015
Seurat; RRID:SCR_016341
SPRING Weinreb et al., 2018 https://kleintools.hms.harvard.edu/tools/
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MAST software Finak et al., 2015 MAST; RRID:SCR_016340
Ingenuity Pathway Analysis QIAGEN Ingenuity Pathway Analysis; RRID:SCR_008653
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Cell Reports 30, 3149–3163.e1–e6, March 3, 2020 e2
stock #007906) (Madisen et al., 2010). For constitutive endocardial genetic tracing, the same reporter was crossed with B6.Cg-
Tg(Tek-cre)12Flv/J mice (TekCre; JAX stock #004128) (Koni et al., 2001). The previously described Col1a1eGFP transgenic mice
were used as a cardiac fibroblast marker for validation experiments (Yata et al., 2003). Nine different inbred strains were subjected
to myocardial infarction to evaluate the reparative outcome: NZO/HlLtJ (JAX stock #002105), WSB/EiJ (JAX stock #001145), NOD/
ShiLtJ (JAX stock #001976), 129S1/SvImJ (JAX stock #002448), PWK/PhJ (JAX stock #0003715), CAST/EiJ (JAX stock #000928), A/J
(JAX stock #000646), C57BL/6J (JAX stock #000664) and DBA/2J (JAX stock #000671).
METHOD DETAILS
Myocardial infarction
Myocardial infarction was performed as previously described (Salimova et al., 2019) on young adult males (10-12-week-old.) Briefly,
the left anterior descending branch of the coronary artery (LAD) was permanently ligated above branching, about 1mm below the tip
of the left auricle. Only mice with > 30% left ventricular ischemia were used for analysis. The mouse thoracic cavity was then closed
and sutured. Sustained release 0.05 mg/g buprenorphine gel formulation was administered subcutaneously at the time of surgery for
analgesia. Bipuvicane has administered locally to chest suture site. Mice were individually monitored daily for the first 7 days, fol-
lowed by weekly monitoring until the endpoint of experiments. Survival rates were also assessed at 28 days. Myocardial rupture
(days 3-5) was confirmed by necropsy. Sudden death (days 0-1) was determined by death in the absence of rupture. Heart failure
was determined by assessment of body condition score (poor mobility, grooming, hunching, etc) on live animals before euthanasia.
Sham surgeries were performed in the sameway as infarcts, except that after pericardial tearing the animal was sutured without liga-
tion of the coronary artery. Functional analyses were performed at baseline (before surgery) and 28 days post-surgery. Vevo 2100
ultrasound imaging system (FUJIFILM/VisualSonics Inc., Canada) was used for morphological and functional evaluation of hearts.
Animals were anesthetized with isoflurane with controlled body temperature and heart rate for functional imaging. Baselinemeasure-
ments were obtained using parasternal long (PSLAX) and short (SAX) axis B-mode imaging. Used parameters were endocardial and
epicardial length and area in systole and diastole.
Single Cell Isolation
The protocol for cell isolation was adapted from Chong et al. (2011). Heart ventricles were dissociated, mechanically cut into small
pieces with a scalpel and subjected to two 15min digestionswith 263U/ml collagenase type II (Worthington Biochemical Corporation,
LS004177), under magnetic stirring at 250rpm, 37C. The cell suspension was passed through a 40 mm cell strainer to remove car-
diomyocytes, small fragment of undigested tissue and collected on ice in a conical 50ml tube containing 2%FCS (VWR Seradigm,
97068-085) in PBS. Cells were spun at 300g for 5 min and pre-warmed red cell lysis buffer (Sigma-Aldrich, R7757) was added for
1 min to remove blood cells. After washing, cell pellets were resuspended in 200 mL Dead Cell Removal MicroBeads (Miltenyi Biotec,
130-090-101) and incubated 10min at room temperature in the dark. Themix of cells and beadswas diluted in binding buffer (Miltenyi
Biotec, 130-090-101) and an AutoMACS Separator was used to deplete dead cells bound to the magnetic beads.
After centrifugation at 400g for 5 min, cells were resuspended in 2%FCS+2mM EDTA and stained with 2mMDRAQ5 (eBioscience,
65-0880-92) followed by 3 mM Propidium Iodine (Sigma-Aldrich, P4864) after 5min. Single live nucleated cells were sorted on a BD
AriaII with 130mm nozzle to minimize pressure over cells (12psi). 16-32,000 events were sorted in 0.04%BSA, centrifuged for 8min at
400g, resuspended and diluted to 320-400cells/ml for scRNaseq (10x Genomics).
Single-cell transcriptome barcoding and library preparation for Illumina sequencing
Single cell capture, barcoding and library preparation were performed with the 10x Chromium system using version 2 chemistry, ac-
cording to the manufacturer’s protocol (10x Genomics, #CG00052). Approximately 12,000 cells were loaded into one lane of a 10x
Chromiummicrofluidic chip. 1 channel was used per sample (11 total) on 3 chips. Following capture and lysis, cDNAwas synthesized
and amplified (12 cycles) as per manufacturer’s protocol (10x Genomics). The amplified cDNA from each channel was used to
construct an Illumina sequencing library. cDNA and libraries were checked for quality on an Agilent 4200 TapeStation, quantified
by KAPA qPCR, and sequenced on an Illumina HiSeq 4000 with 150 cycle sequencing to an average depth of 46,000 reads per
cell. Detailed information on the cDNA and library yield, sequencing saturation and estimated number of captured cells per sample
can be found in Table S1.
Single-cell RNA-seq data analysis
Processing of sequencing reads
Raw Illumina data were processed using CellRanger v2.1 (10x Genomics) to convert Illumina basecall files to FASTQ format, align
sequencing reads to the appropriate genome using the STAR aligner (Dobin et al., 2013), and quantify gene expression. For cells
isolated from B6J mice, the mouse reference genome (GRCm38/mm10) was used with an extra contig added to allow alignment
of reads derived from transgenic ZsGreen sequence. Specifically, the sequence of the plasmid used to generate the transgenic
mouse was obtained from http://www.addgene.org/browse/sequence/162422/. The 1680bp used sequence included the complete
ZsGreen coding sequence, a downstream 589bp WPRE sequence, and the poly(A) signal. For cells isolated from 129 mice, variant
calls from the Mouse Genomes Project (Keane et al., 2011) were obtained and g2gtools (https://github.com/churchill-lab/g2gtools)
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was used to replace single nucleotide variants, insertions, and deletions in the reference genome to create a 129-specific reference
genome towhich readswere aligned. Individual sequencing runswere processed using the ‘‘cellranger count’’ command, and aggre-
gated runs from all time points processed using the ‘‘cellranger aggr’’ command, specifying argument ‘‘–normalize=mapped’’ for
depth normalization.
Data quality control, normalization, clustering, and marker analysis
The Seurat software package version 2.3.4 (Butler et al., 2018; Macosko et al., 2015) was used in R version 3.4.1 (R Development
Core Team, 2017) to analyze processed scRNA-Seq data. Data from 38,555 cells that passed CellRanger’s quality control steps
were obtained. 36,847 cells were retained after filtering out cells in which < 500 or > 5,000 genes were detected; > 10% of reads
derived from mitochondria; or > 15,000 UMIs were sequenced. Expression of 27,999 transcripts was quantified, of which 18,862
were expressed in at least one cell. Read counts were normalized using log transformation. Cell cycle stage was estimated and re-
gressed out using methods implemented in Seurat (and detailed at https://satijalab.org/seurat/v3.0/cell_cycle_vignette.html). In
addition to cell cycle stage, the number of genes detected, number of UMIs detected, and percentage of mitochondrial reads
were also regressed out. Variable genes were detected using the Seurat function FindVariableGenes with default parameters except
y.cutoff = 0.5. Dimensionality reduction was used to explore transcriptional heterogeneity and for clustering. Specifically, PCA was
used for dimensionality reduction. The first 24 principal components (PCs) were used as input for a graph-based approach to cluster
cells by cell type using resolution 0.5 and as input to t-SNE for reduction to two dimensions to facilitate visualization (Villani et al.,
2017).
Average expression of all genes per time-point and per cluster were obtained. Two Seurat functions were employed to identify
marker genes: FindAllMarkers() to compare each cluster with all the others, and FindMarkers() for pairwise comparisons among clus-
ters/sub-clusters. For each marker gene of clusters, the average fold change (avg_logFC), percentage of expression in each specific
cluster (pct.1), percentage of expression in all the other clusters (pct.2), and adjusted p-value (p_val_adj) were calculated, as reported
in Tables S2, S3, and S4). Avg-logFC was chosen to represent cluster-specific markers.
SPRING visualization
The used SPRING (Weinreb et al., 2018) viewer web-interface that can be found at https://kleintools.hms.harvard.edu/tools/spring.
html. For visualization, the following parameters were used: Number of PCA dimensions = 25; Gene filtering - minimum counts = 3;
Gene filtering - gene variability percentile = 80.0; Number of nearest neighbors = 5; Cell filtering -minimum counts = 0.0; Gene filtering
- minimum cells = 3.0. Data matrixes of clusters of interest retrieved from the Seurat object containing all time-points were uploaded.
List of genes, clustering and temporal information derived from meta data associated with the Seurat objects were also provided.
Stromal cell sub-clustering
In order to explore transcriptional heterogeneity within stromal cell clusters, the complete matrix of single cell transcriptomes and the
data from selected populations (Fibroblasts I, Fibroblasts II, Fibroblasts III, Myofibroblasts and Epicardium; clusters 0,4,6,7,12) were
re-normalized and clustered. Specifically, highly variable genes were identified, and the gene expression matrix was reduced in
dimensionality using PCA. The first 20 PCs were selected and a graph-based clustering method implemented in Seurat was em-
ployed to cluster cells (resolution 0.5).
Doublets prediction
Cell doublets were predicted using DoubletFinder version 2.0.2 (McGinnis et al., 2019, https://github.com/chris-mcginnis-ucsf/
DoubletFinder). DoubletFinder identifies doublets according to each cell’s gene expression proximity to artificial doublets created
by averaging the transcriptional profile of randomly chosen cell pairs. DoubletFinder was run independently on each single cell library
from the 7 time point experiment, to ensure that simulated doublets did not include cells from different libraries which would be
impossible to observe. For all libraries, a 6% (true) doublet rate was assumed, 25 principal components were used, and the default
value of 25% was used for pN (the number of generated artificial doublets expressed as a proportion of the merged real-artificial
data). For each library, the PC neighborhood size pKwas estimated using as themaxima of the distribution of mean-variance normal-
ized bimodality coefficient scores, as suggested by the developers.
Integration of data from different murine strains
Single cell transcriptomes derived frommice of different genetic backgrounds require careful integration before joint analysis can be
performed. In particular, the same cell type may show variability in gene expression in genetically distinct mice due to genetic regu-
lation of gene expression. The Harmony R package version 0.0.0.9000 (Korsunsky et al., 2019) was used to integrate data from B6J
and 129 cells. This software takes cells from the strains and projects them onto a shared embedding, allowing for joint clustering and
analysis of the combined data. Before running Harmony, data were processed using simple criteria with the Seurat package. First,
raw data matrices were read from each 10x Chromium sample. 18,006 genes quantified in both B6J and 129 backgrounds were
retained for further analysis. Second, cells were filtered using automated criteria. Cells with a very low or high number of UMIs or
number of genes expressed were filtered (minimum 1000 UMI and 500 genes expressed; cells with a UMI [number of genes] count
greater than three standard deviations from the mean UMI [number of genes] count of all cells were discarded). Furthermore, cells
with > 30% mitochondrial reads were discarded. Third, the top 1000 variable genes were identified. Fourth, data were normalized,
with signal due to the number of UMI and percent mitochondrial reads regressed out. Fifth, PCA was conducted on the
complete dataset including B6J d0 - 6608 cells; B6J sham, n = 2 - 4710 cells; 129 sham - 4213 cells; d3 MI B6J - 3950 cells; d3
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MI 129 - 4128 cells. To run Harmony, 80 PCs were used and the RunHarmony() function available at https://github.com/
immunogenomics/harmony was used to integrate data with parameters: theta = 1; max.iter.harmony = 20. Finally, t-SNE was
computed and cells were clustered using the graph-based clustering method implemented in Seurat.
Differential gene expression across different strains
The MAST software(Finak et al., 2015) was used to enquire differential gene expression between strains in different conditions (sham
and d3 post-MI). Tests were carried out using the MASTcpmDetRate method (Soneson and Robinson, 2018).This method tests for
differences using log- and library size-normalized counts, with cellular detection rate as a covariate, andwas among themost power-
ful and accurate methods for differential expression analysis of single cell RNA-Seq (Soneson and Robinson, 2018). Analysis of the
differentially expressed genes to identify enrichment of particular biological functions was performed using Ingenuity Pathway Anal-
ysis (QIAGEN) and Panther (Mi et al., 2019). The score of each relevant GO-term was calculated as the ratio of the number of query
genes associated with the term divided by the total number of genes in the genome associated with the term. Lists of mouse genes
associated with each GO term were obtained from the Mouse Genome Informatics database at the link http://www.informatics.jax.
org/downloads/reports/gene_association.mgi.gz (accessed January 14, 2019).
Tissue processing for cryosectioning
Following animal euthanasia, hearts were perfused with 1x HBSS, transferred to 0.5mM KCl for cardiac cycle arrest in diastole, fixed
in 4% paraformaldehyde (PFA) for 30min-1 hour at 4C, permeated with 30% sucrose overnight at 4C and embedded in Fisher
Healthcare Tissue OCT Compound on dry ice. 8 mm cryosections were obtained using the Cryostar NX70 (Thermo Fisher).
Immunofluorescence
Cryosections were dried for two hours at room temperature, re-fixed in 2%PFA for 10min, permeabilizedwith 0.5%Triton for 15min,
blocked with 5% BSA in 50mM Glycine PBS, and stained with primary antibodies diluted in blocking solution, overnight at 4C. The
following antibodies were used:WT1(1:100, Abcam, ab89901), DKK3 (1:100, R&D Systems, AF948), CTHRC1 (1:100, Thermo Fisher,
PA5-49638), ACTA2 (1:100, Sigma Aldrich, A5228, clone 1A4), MT1a (1:100, Enzo Life Sciences, ADI-SPA-550-D), CD45 (1:100, BD
Biosciences, 550539, clone 30-F11), CLU (1:100, MyBioSource, MBS9215265, clone RB18701), SFRP2 (1:50, R&D Systems,
MAB1169, clone 331022). Used secondary antibodies were Invitrogen Alexa Fluor 568 Donkey anti-Goat (A-11057), Goat anti-Mouse
(A-11031), Goat anti-Rabbit (A-11011); Alexa Fluor 647 Goat anti-Rat (A-21247), Goat anti-mouse IgG2a (A-21241), and Goat anti-
Rabbit (A-21244) diluted 1:500 or 1:1000 in PBS. Nuclei were stained with DAPI (0.1mg/ml, Thermo Fisher, D1306).
Imaging
Bright field and fluorescent wholemount images of full hearts were captured on a stereo-microscope (Leica,MZ10F), equippedwith a
color/fluorescence camera (Leica, DFC 450c). Scale bars were added and images processed using the LAS software v4.8. Immu-
nofluorescence images were acquired using either an upright fluorescent microscope (Zeiss, Axio Imager.Z2), equipped with
X-Cite 120LED excitation source (Excelitas Technologies), using a 20x objective (Zeiss, Plan-Apochromat’’ 20x/0.8), and the
ZEN2 software (Zeiss, blue edition) for acquisition, or using confocal imaging (SP8-AOBS, Leica) with 40x (Leica, HC PL APO
40x/1.30 Oil CS2, FWD = 0.24 mm) or 63x (Leica, HC PL APO 63x/1.40 Oil CS2, FWD = 0.14) objectives, using very-high sensitivity
HyD detectors for the emission of 488, 561 and 633 lasers, and the LASX software. At least 3 independent rounds of stainings were
done and images were acquired keeping same setting across all time-points used in the comparison analysis. All quantification and
image processing were performed using Fiji version 1.0 (Schindelin et al., 2012). Z stacks with 0.5 mm step size were converted by
Z-projection of the average intensity for each channel. Individual channels were merged and pseudo-colored.
Flow cytometry and cell sorting for bulk RNA isolation
For qPCR validations, interstitial cells were isolated as described above, from the whole ventricles of control mice or scar area and
distal area in injured mice. In experiments with Coll1a1eGFPmice, GFP+DRAQ5+PI- cells were sorted on Aria II with 130 mm nozzle. In
absence of a fluorescent reporter (129, B6J mice), cells were first resuspended in blocking solution containing anti-mouse CD16/
CD32 (1:600, Leinco Technologies, C381, clone 2.4G2) in 2% FCS 5min at RT, then stained with APC/Cyanine7 anti-mouse CD45
(1:660, BioLegend, 103115, clone 30-F11), PE-Cy7 anti-mouse CD31 (1:800, BD Biosciences, 561410, clone 390) on ice for
15min. After washing in PBS, cells were resuspended in 2%FCS+2mM EDTA and DAPI (50ng/ml) before sorting on the AriaII for
DAPI-CD45-CD31-cells.
RNA extraction and quantitative PCR
RNA was isolated from bulk sorted cells using the RNAqueous-Micro Total RNA Isolation Kit (Thermo Fisher, AM1931), according to
manufacturer’s instructions. cDNA synthesis was performed using the SuperScript IV VILO Master Mix with ezDNase Enzyme
(Thermo Fisher, 11766050). qPCR reactions were performed using Power SYBR Green PCR Master Mix (Thermo Fisher,
4367659) on ViiA 7 Real-Time PCR System with 384-Well Block (Thermo Fisher). 4ng of RNA were loaded per reaction. Primers
were designed using IDT primer design tool and BLAST, tested with standard curves on 4 serial 5-fold dilutions. The following
primers were used: Comp F: 50-ACATAGATGGCGACCGAATAC-30, R: 50-CCTCTGGTCTGGGTTATCTTTC-30; Acta2 F:
50-TCTTTCATTGGGATGGAGTCAG-30, R: 50-GACAGGACGTTGTTAGCATAGA-30; Cthrc1 50-CCCATCGAAGCCATCATCTATC-30,
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R: 50-TCACAGAGTCCTTCCACAGA-30; Sfrp2 F: 50-AGAGGAAGCTCCCAAGGT-30, R: 50-GGTGTCTCTGTTGATGTACGTTAT-30;
Ecrg4 F: 50-CTGGGTCCAGATGGCATAAG-30, R: 50- GTTCTCGGCTACAGCTACATT-30; Wisp2 F: 50-TTGAAGCTGGCTCCAC
AAG-30; R: 50-GGGCATACACCATTGAGAGAAT-30; Meox1 F: 50-GGGAGGATTGCATGGTACTT-30, R: 50-CTGGTTGTCTG
ACCTCTCTTT-30; Col8a1 F: 50-GCTCAAGAAGCTGTTCTGTAAATC-30, R: 50-CCAGTAGAATCGAGGACCAAAG-30; Tnc F: 50-CC
AGGGTTGCCACCTATTT-30, R: 50-GTCTAGAGGATCCCACTCTACTT-30; Thbs4 F: 50-GCTCCTTGGAGAGGTGAAAG-30, R: 50-AA
AGCTGAGAGGACCACAAG-30; Cxcl14 F: 50-GCTCTTGGTGGTGACGATAA-30, R: 50-GCTACAGCGACGTGAAGAA-30; Saa3 F:
50-GCCTTCCATTGCCATCATTC-30, R: 50-CACATGTCTCTAGACCCTTGAC-30; Serpina3n F: 50-TGCAGTCTACAGAGCTGAAA
CC-30, R: 50-CAACCCTGAACATCGGGAGT-30; Fn1 F: 50-TCCTGTCTACCTCACAGACTAC-30, R: 50-GTCTACTCCACCGAACAA
CAA-30; F2r F: 50-TGGAGGGTAGGGCAGTCTAC-30, R: 50-GTGTACACGGAGGGCATGAA-30; Serpine1 F: 50-TCCACAAGTCT
GATGGCAGC-30, R: 50-TGGTAGGGCAGTTCCACAAC 30; Plat F: 50-CGAAAGCTGACGTGGGAATA-30, R: 50-GTGTGAGGT
GATGTCTGTGTAG-30; Anxa2 F: 50-CAAGACCAAAGGAGTGGATGAG-30, R: 50-CTGATAGGCGAAGGCAATGT-30; Dcn F:
50-CTGGCCAATGTTCCTCATCT-30, R: 50- AAGGTAGACGACCTGGATATACT-30;Col5a1 F: 50-CACCTTGATCCTCGACTGTAAG-30,
R: 50-TGTTGGATGTCACCCTCAAATA-30; Col4a2 F: 50-ACAATCACCACCAAAGGGGA-30, R: 50-GGAATCCATCCAGCCCATCC-30;
Fbln5 F: 50-TGTCTGCGTTTGCTCTATGT-30, R:50-GAGTATCATGCGTCTCTGTCTG-30; Mfap5 F: 50-AGTCCTGCTTCACCAGTT
TAC-30, R: 50-GGCAAAGCTCATCTTTCATAGC-30; Thbs1 F: 50-GCCTCTCCTGTGATGAACTATC 30, R: 50-CTCTGTTCT
CTTCCGTCACTTT-30; Serping1 F: 50-GCTGAGAACACCAACCATAAGA-30, R: 50-CCACTTGGCACTCAAGTAGAC-30; Tgfb1 F:
50-CTGAACCAAGGAGACGGAATAC-30,R: 50-GGGCTGATCCCGTTGATTT-30; Hprt1 (Furtado et al., 2014) F: 50-GCGAGGGA
GAGCGTTGGGCT-30, R: 50-CATCATCGCTAATCACGACGCTGGG-30; Rpl4 (Ruiz-Villalba et al., 2017) F: 50-GCC
GCTGGTGGTTGAAGATAA-30, R: 50-CGTCGGTTTCTCATTTTGCCC-30.
QUANTIFICATION AND STATISTICAL ANALYSIS
Number of biological replicates and statistical significance are specified in figures and figure legends. For Echocardiography baseline
measurements of B6J (n = 14) and 129 (n = 13) strains, an average of 3 measurements of each parameter were obtained per animal
(standard deviation < 0.5). To evaluate the response to MI of different inbred strains the following mice were used: NOD/ShiLtJ,
n = 13, NZO/HILtJ, n = 16, 129S1/SvlmJ, n = 34, DBA/2J; n = 9, A/J; n = 14, CAST/EiJ, n = 18; WSB/EiJ, n = 12, PWK/PhJ,
n = 11, C57BL/6J n = 13.
For immunostaining quantification, we used 5-6 fields per time-point and calculated mean and standard error of the mean. Un-
paired, two-tailed Student’s t test was used for pairwise comparison of data between groups. P value of less than 0.05 was consid-
ered significant. For qPCR analysis we used 3 technical replicates of 3 biological replicates. We calculated e^ - DDCt, where e is the
efficiency of each primer pair derived from the standard curve, DDCt is obtained by normalizing Ct values on the geometric mean of
two housekeeping genes (Rpl4 and Hprt1) over the refence sample. The median, 25th and 75th percentile, maximum and minimum
values are represented with box and whisker plots. For statistical analysis, unpaired two-tailed Student’s t test, which compares the
relative expression values of each gene to the values of the reference sample used for normalization. P-value of less than 0.05 was
considered significant. Excel v16.16.7 and GraphPad Prism v7.0 were used for the analysis, generation of graphs and statistics. For
differential gene expression analysis between 129 and B6J, a threshold of 2-fold expression change and P-value%0.01 were used.
False discovery rate (FDR)-corrected P-values were used for sorting the results from Panther analysis. P-values of overlap and
Benjamini-Hochberg (B-H) corrected P -values were used for the upstream regulators and canonical pathway analysis respectively
(Ingenuity Pathway Analysis, QIAGEN). For the Kaplan-Meier survival plot, statistical significance was calculated using the Gehan-
Breslow-Wilcoxon test.
DATA AND CODE AVAILABILITY
Data resources
R scripts utilized in the study can be obtained upon request. The accession number for the sequencing data reported in this paper is
ArrayExpress: E-MTAB-7895.
Cell Reports 30, 3149–3163.e1–e6, March 3, 2020 e6
